Literature DB >> 11547224

Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population.

A P Barbosa1, J L Medina, E P Ramos, H P Barros.   

Abstract

OBJECTIVE: Distal symmetrical polyneuropathy in diabetics (DPN) has a variable prevalence around 30% and increases the risk for foot ulcers and amputations. We aimed at evaluating the prevalence of clinical DPN and associated risk factors in patients followed in primary care centers.
MATERIAL AND METHODS: 101 type 2 diabetics were evaluated and 8 were excluded due to the presence of other causes of neuropathy. The remaining 93 had a mean age of 65.4 +/- 10.1 years and a mean diabetes duration of 10.1 +/- 11.1 years, 60.2% were women and 39.8% men. DPN was defined as the presence of both altered sensitivities and reflexes, regardless of symptoms.
RESULTS: Seventy-two (80%) patients had symptoms of polyneuropathy, but DPN was present only in 29 (32.2%). Calluses (37.8%) and trophic skin (74.4%) and nail (75.6%) changes were found in both feet. There was a significant positive association of DPN with age (69.0 +/- 9.1 vs 63.3 +/- 9.9 years, p=0.01), disease duration (15.7 +/- 13.5 vs 7.2 +/- 8.8 years, p=0.001), feet skin changes (38.8 vs 13.0%, p=0.04) and myocardial infarction/ischemia (14.8 vs 1.7%, p=0.03).
CONCLUSIONS: This sample of diabetic patients cared by family doctors presented a high prevalence of DPN. Aging, disease duration, the presence of feet skin changes and myocardial infarction/ischemia are factors that increase the prevalence of the disease. Primary care doctors awareness of the problem might help to decrease the associated morbidity.

Entities:  

Mesh:

Year:  2001        PMID: 11547224

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  14 in total

1.  Risk Factors For Diabetic Polyneuropathy.

Authors:  Yüksel Kaplan; Semiha Kurt; Hatice Karaer Ünaldi; Ünal Erkorkmaz
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

Review 2.  The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.

Authors:  Carole Clair; Marya J Cohen; Florian Eichler; Kevin J Selby; Nancy A Rigotti
Journal:  J Gen Intern Med       Date:  2015-05-07       Impact factor: 5.128

3.  Serum prolidase activity and oxidative status in patients with diabetic neuropathy.

Authors:  Ertugrul Uzar; Yusuf Tamam; Osman Evliyaoglu; Alpaslan Tuzcu; Coskun Beyaz; Abdullah Acar; Birsen Aydın; Nebahat Tasdemir
Journal:  Neurol Sci       Date:  2011-11-27       Impact factor: 3.307

Review 4.  Diabetic foot screening: why is it neglected?

Authors:  Ma'en Zaid Abu-Qamar
Journal:  Int Wound J       Date:  2006-09       Impact factor: 3.315

5.  Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh.

Authors:  Kjersti Mørkrid; Liaquat Ali; Akhtar Hussain
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

6.  Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy.

Authors:  Refah Sayın; Mehmet Aslan; Mehmet Emin Kucukoglu; Arda Luleci; Murat Atmaca; Ramazan Esen; Halit Demir
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

Review 7.  The efficacy of physiotherapy interventions in mitigating the symptoms and complications of diabetic peripheral neuropathy: A systematic review.

Authors:  Narges Jahantigh Akbari; Mohammad Hosseinifar; Sedigheh Sadat Naimi; Saeed Mikaili; Soulmaz Rahbar
Journal:  J Diabetes Metab Disord       Date:  2020-10-12

8.  Potential risk factors for diabetic neuropathy: a case control study.

Authors:  Fargol Booya; Fatemeh Bandarian; Bagher Larijani; Mohammad Pajouhi; Mahdi Nooraei; Jamshid Lotfi
Journal:  BMC Neurol       Date:  2005-12-10       Impact factor: 2.474

9.  Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life.

Authors:  N Ovayolu; E Akarsu; E Madenci; S Torun; O Ucan; M Yilmaz
Journal:  Int J Clin Pract       Date:  2008-04-10       Impact factor: 2.503

10.  Prevalence of risk factors for diabetic foot complications.

Authors:  Fatma Al-Maskari; Mohammed El-Sadig
Journal:  BMC Fam Pract       Date:  2007-10-10       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.